Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer and auto-immune disease. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
Our success is rooted in four key elements:
- Our track record reflected by a portfolio of successful approved medicines which emanated from our chemistry platform and are made available globally by our pharmaceutical partners
- Our unique research and development pipeline of new investigational medicines in cancer and immunology
- Our proprietary and proven science and technology approach that fuels our discovery efforts
- Our team of dedicated scientists, clinicians and employees focused on bringing new medicines to patients with debilitating diseases